VIGOR Study Design Endpoints - Efficacy

• Not designed as an efficacy study

  • Non-flare design
  • Change in DMARD therapy, systemic and intra-articular corticosteroids allowed; rescue analgesia at the investigator’s discretion
    
  • Some efficacy endpoints included. No measurement of swollen joints, tender joints, ESR/CRP

Previous slide

Next slide

Back to first slide

View graphic version